By exploring the highly competitive sub-network of the LMCN, we determined that MCM3AP-AS and MIR17HG comprised a ceRNA regulating module that competed with MATR3, ZCCHC14, and XPO1, which was associated with GBM prognosis [38]. The gene discussed is MIR17HG; the disease is glioblastoma.